Home
>
National Drug Code (NDC)
>
Fabrazyme
Fabrazyme - 58468-0041-1 - (AGALSIDASE BETA)
Drug Information of Fabrazyme
| Product NDC: | 58468-0041 |
| Proprietary Name: | Fabrazyme |
| Non Proprietary Name: | AGALSIDASE BETA |
| Active Ingredient(s): | 5 mg/mL & nbsp; AGALSIDASE BETA |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fabrazyme
| Product NDC: | 58468-0041 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103979 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20081217 |
Package Information of Fabrazyme
| Package NDC: | 58468-0041-1 |
| Package Description: | 1 mL in 1 VIAL, GLASS (58468-0041-1) |
NDC Information of Fabrazyme
| NDC Code | 58468-0041-1 |
| Proprietary Name | Fabrazyme |
| Package Description | 1 mL in 1 VIAL, GLASS (58468-0041-1) |
| Product NDC | 58468-0041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | AGALSIDASE BETA |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081217 |
| Marketing Category Name | BLA |
| Labeler Name | Genzyme Corporation |
| Substance Name | AGALSIDASE BETA |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
